intravitreal ranibizumab

DRUG12 trials

Conditions

Age Related Macular DegenerationAge-Related Macular DegenerationChoroidal NeovascularizationDiabetic Macular EdemaDiabetic RetinopathyEpiretinal MembraneEye DiseasesGlaucoma, Neovascular

Phase 2

Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration

CompletedNCT01162746

Medical University of ViennaAge-Related Macular Degeneration, Neovascularization, Choroidal

Start: 2011-10-31End: 2015-12-31Updated: 2017-05-25

Phase 3

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

CompletedNCT00429962

University Hospital, Basel, SwitzerlandAge-Related Macular Degeneration, Choroidal Neovascularization

Start: 2006-07-31End: 2008-06-30Updated: 2009-04-07

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

NCT02914626

LEANDRO CABRAL ZACHARIASGlaucoma, Neovascular, Ranibizumab

Start: 2016-10-31End: 2018-10-31Target: 28Updated: 2016-09-27

Phase 4

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

CompletedNCT01922154

Siriraj HospitalGlaucoma, Neovascular

Start: 2009-02-28End: 2012-12-31Updated: 2021-07-16

Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab

NCT03056092

Unity Health TorontoAge Related Macular Degeneration, Diabetic Macular Edema, Macular Edema +1

Start: 2017-02-28End: 2024-02-28Target: 168Updated: 2021-04-28

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

CompletedNCT03690947

Beijing HospitalDiabetic Macular Edema

Start: 2018-10-01End: 2021-09-30Updated: 2022-12-28

Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema

TerminatedNCT04991350

Cairo UniversityDiabetic Macular Edema, Diabetic Retinopathy, Macular Ischemia +1

Start: 2021-11-26End: 2022-11-01Updated: 2023-02-16

Unknown Phase

Treatment of Epiretinal Membranes With Ranibizumab

CompletedNCT01238393

Queen's UniversityEpiretinal Membrane

Start: 2010-11-30End: 2012-01-31Updated: 2016-01-13

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

NCT01626339

University of MalayaAge Related Macular Degeneration

Start: 2012-04-30Target: 30Updated: 2012-06-22

Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuity

Active, not recruitingJPRN-UMIN000015073

Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciencesneovascular age-related macular degeneration

Start: 2013-01-10Target: 40Updated: 2026-06-29

Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab

CompletedNCT03115255

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineInfant, Premature, Diseases

Start: 2017-05-01End: 2018-06-30Updated: 2018-10-12

Comparison of Ziv-aflibercept and Ranibizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Active, not recruitingPACTR202609559057862

Ahmed Abdelrahman Mohamed Mohamed SaberEye Diseases

Start: 2024-10-01Target: 18Updated: 2026-09-14

Related Papers

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.

2022-09-023 citations